Boosting Wnt Signaling Reverses APOE4 Alzheimer’s Damage

The researchers demonstrated that restoring Wnt signaling pharmacologically

MIT neuroscientists have identified how the APOE4 gene variant disrupts brain cell function by suppressing Wnt signaling in oligodendrocytes, leading to the harmful accumulation of fatty acids in lipid droplets instead of their use in forming protective myelin sheaths around neurons. This discovery, made through whole-genome CRISPR screening and chromatin profiling, reveals a key mechanism by which APOE4 increases Alzheimer’s disease risk and suggests a potential therapeutic target. The study found that in brain cells carrying the APOE4 variant, Wnt signaling—a pathway critical for cell development and maintenance—is significantly reduced. As a result, oligodendrocytes fail to properly metabolize lipids, causing essential fatty acids to become trapped in toxic lipid droplets. These droplets interfere with cellular function and prevent the formation of myelin, which is vital for efficient neural communication.

Health news

Ethical Decision-Making for Mental Health Professionals Using Large Language ModelsAI Discovers Hidden Health Data in Everyday CT ScansUltra‑Processed Food Drives Up National Health Costs by $360,000 a YearScientists engineer CAR-NK immune cells directly inside the body using mRNA nanoparticles

The researchers demonstrated that restoring Wnt signaling pharmacologically reversed these effects, allowing lipids to be used correctly for myelin production and reducing lipid droplet buildup. How Wnt Signaling Supports Myelin Formation in Oligodendrocytes Wnt signaling plays a direct role in regulating genes involved in lipid metabolism and myelin synthesis. When this pathway is active, it promotes the expression of proteins that transport and process fatty acids for myelin construction. In APOE4-carrying cells, the suppression of Wnt signaling disrupts this process, shifting lipid handling toward storage rather than utilization. The team used chromatin profiling to confirm that key myelin-related genes were less accessible for transcription in these cells, directly linking APOE4 to impaired gene regulation via Wnt pathway inhibition. Can Targeting Wnt Signaling Prevent Myelin Damage in APOE4 Carriers?

Yes, the researchers showed that administering compounds known to activate Wnt signaling restored normal lipid metabolism in oligodendrocytes derived from APOE4-positive cells.

This intervention reduced lipid droplet formation and increased myelin protein

This intervention reduced lipid droplet formation and increased myelin protein expression, suggesting that pharmacological enhancement of Wnt signaling could counteract one of the early cellular defects linked to APOE4. While these results are promising, the team cautions that further studies are needed to determine whether such approaches can delay or prevent cognitive decline in human carriers of the APOE4 variant. Frequently Asked Questions What is the role of oligodendrocytes in the brain? Oligodendrocytes are glial cells responsible for producing myelin, the fatty substance that insulates nerve axons and enables fast, efficient electrical signaling between neurons.

Why does APOE4 increase the risk of Alzheimer’s disease? APOE4 interferes with lipid processing in brain cells, particularly oligodendrocytes, leading to the accumulation of toxic lipid droplets and reduced myelin formation, which compromises neural function over time.

Is Wnt signaling activation currently being tested in Alzheimer’s clinical trials? While Wnt pathway modulators are being explored in preclinical studies for neurodegenerative diseases, no Wnt-targeting therapies have yet entered clinical trials specifically for Alzheimer’s disease in APOE4 carriers.